Rubicon Research (RUBICON)
FAST GROWERFairStock Score: 55/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹927.75 |
| Market Cap | ₹12,856.29 Cr |
| P/E Ratio | 76.33 |
| ROCE | 26.05% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 91.23% |
| Debt/Equity | 0.88 |
| Sales Growth | 51.73% |
| Free Cash Flow | ₹9,400 Cr |
| Promoter Holding | 59.99% |
| 52-Week Range | ₹570.75 — ₹1,371.75 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹46.8 |
Rubicon Research trades with a P/E ratio of 76.33, ROCE of 26.05%, profit growth of 91.23%, debt-to-equity of 0.88. The FairStock Score of 55/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer